Global Cardio Oncology Registry

Overview

About this study

The purpose of this study is to provide a large database and platform for prospective sub-studies and eventually develop additional collaborations with a platform for clinical studies and trials following the initial pilot phase.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

- New cardio-oncology consultation for breast cancer patients; or

- New cardio-oncology consultation for Hodgkin's or non-Hodgkin's lymphoma patients; or

- New cardio-oncology consultation for acute or chronic leukemia patients; or

- New cardio-oncology consultation for multiple myeloma or AL amyloidosis; or

- New cardio-oncology consultations for immune check-point inhibitors cardiac
evaluation.

- All patients have to be 18 years old or older.

Exclusion Criteria:

- Cardio-oncology patients who have previously had cardio-oncology evaluation and follow
up by the investigators.

- Minors less than 18 years old.

- Inability or unwillingness to consent to participate.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/2/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Joerg Herrmann, M.D.

Open for enrollment

Contact information:

Preventive Heart Research Team

(507) 538-7425

RSTCRVRUPREVENT@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions